Arxis Securities LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,245 shares of the healthcare conglomerate’s stock, valued at approximately $532,000. UnitedHealth Group accounts for about 2.8% of Arxis Securities LLC’s investment portfolio, making the stock its 11th largest position.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC raised its stake in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the last quarter. Thomas J. Herzfeld Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $111,000. Cribstone Capital Management LLC raised its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the last quarter. Israel Discount Bank of New York GFN purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $139,000. Finally, Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) traded down 0.98% on Friday, hitting $190.82. The stock had a trading volume of 2,858,501 shares. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The stock has a market cap of $184.50 billion, a price-to-earnings ratio of 22.92 and a beta of 0.64. The stock’s 50 day moving average is $190.49 and its 200 day moving average is $175.87.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by BNB Daily and is the property of of BNB Daily. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/arxis-securities-llc-invests-532000-in-unitedhealth-group-incorporated-nyseunh-updated-updated-updated.html.
Several equities analysts recently commented on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 21st. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a research report on Tuesday, May 30th. Finally, CIBC increased their price objective on shares of UnitedHealth Group from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, April 24th. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $203.41.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock valued at $2,873,320 in the last ninety days. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.